ANDA 84727, held by Pharmaton. Lidocaine Hydrochloride.
As of Nov 16, 2026, ANDA 84727 (Lidocaton), held by Pharmaton, was first approved by FDA on Aug 17, 1983, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 17, 1983 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Lidocaton2% ยท injectable;injection | Lidocaine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters